The Journey of a New Cancer Medicine

From the first chemotherapy in 1949 to the newest targeted treatments, breakthrough medicines have transformed cancer care. Between 1988 and 2000, the life expectancy for cancer patients increased by approximately four years—translating to roughly 23 million additional life years and $1.9 trillion in value added to the economy. This shift represents the results of not only breakthrough discoveries but also a series of smaller medical advances over time.

While ...

Continue reading

Immunotherapy: The Hail Mary Pass to Bill’s Survival

A lesson often learned through sports is to dust yourself off and keep going. Whether you are a professional boxer, a first-time little leaguer, or simply an arm chair quarterback, these words of advice are tried and true.

Bill Nack – author, journalist, sportswriter, and horse racing enthusiast – learned firsthand the importance of getting up and staying in the race.

Born in Chicago, Bill studied communications at the University of Illinois ...

Continue reading

Thankful for Innovation

As the holiday season draws near, we reflect on the things that make us thankful: time spent with loved ones, achievements and milestones reached throughout the year, the promise of another day. 

When it comes to innovation in cancer, we have much to be thankful for:

Clinical trials and research participants: Clinical trials are at the heart of delivering breakthrough medicines to patients and saving lives, and make it possible for patients to receive state-of-the-art ...

Continue reading

Increasing Clinical Research Access and Transparency

Clinical trials are at the heart of delivering breakthrough medicines to cancer patients and are essential to furthering progress in preventing and treating cancer. However, fewer than five percent of adult cancer patients participate in clinical trials, generally due to some common misperceptions about how these studies are conducted. And while the medical benefits of new cancer treatments are routinely reported, adverse events or side effects ...

Continue reading

Defining Value and Patient-Centered Care

Medical innovation saves lives, enhances quality of life, improves public health, and adds economic value to society. But when it comes to assessing the value of medical innovation, patients, policymakers, industry representatives, and insurance companies often evaluate it differently with diverse perspectives.

Historically, a number of decisions doctors and patients make about a person’s medical treatment are oftentimes determined by care plans called

Continue reading

Investing in a Cancer Moonshot

On June 29, Vice President Biden joined more than 350 researchers, oncologists, patient advocates, technology experts, and care providers at Howard University for the first-ever Cancer Moonshot Summit. The Summit was a national day of action, with more than 260 virtual  events also taking place outside of DC. From Miami, Florida to Anchorage, Alaska; Lexington, Kentucky to Biden’s hometown of Wilmington, Delaware, more than 6,000 individuals nationwide discussed the necessary ...

Continue reading

FORCE Releases Survey for Those at Risk of Hereditary Cancers

For those at high-risk of hereditary cancers, regular screening and other measures of preventive care can make a world of difference. But access to treatment isn’t always simple. Without stronger Federal involvement, many insurance companies do not consider preventive care necessary, and therefore decline to cover the cost.

Through harnessing the feedback of patients’ experiences with barriers to insurance coverage, Facing Our Risk ...

Continue reading

Fostering Collaboration through the Cancer Moonshot Initiative

Cancer care no longer depends on one individual or sector. In order for advancement in research to continue, medical professionals, scientists, and patients must collaborate to find new solutions. The Cancer Moonshot Initiative, spearheaded by Vice President Joe Biden, aims to foster these alliances.

Like Cancer Moonshot, ASCO’s Annual Meeting had a similar goal: unite the cancer ...

Continue reading

Immuno-Oncology Clinical and Patient Education Roundtable

Today’s guest post comes from Chelsey Hathaway, Patient Advocacy and Events Manager at the Alliance for Regenerative Medicine (ARM). ARM is an international multi-stakeholder advocacy organization that promotes legislative, regulatory, and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide.

On May 24, patient advocates, industry leaders, and clinicians joined in Washington D.C. for the Alliance for ...

Continue reading

Research Powers Progress Against Cancer

May marks National Cancer Research Month, a time to recognize the tireless efforts of scientists, medical professionals, survivors, and patient advocates who devote their lives to cancer advancements. We focus on the life-changing achievements that result from innovation, and shine a spotlight on the need for furthering it.

From revolutionary imaging techniques to preemptive genetic testing, research and innovation have expanded the spectrum of what is possible in oncology. While ...

Continue reading

More from the blog:

Join the Movement

Sign up to receive emails from Project Innovation and become a part of the movement to accelerate cancer breakthroughs.

We will not share your contact information with third parties.

Share Your Story

Have a cancer story? Help us illustrate the impact of medical innovation by sharing your story here.